I. Tiny wonders of tiny impurities of nitrous oxide during anaesthesia

British Journal of Anaesthesia

Volumn 93, Issue 5, 2004, Pages 619-623

  Marczin, N ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITROUS OXIDE; INHALATION ANESTHETIC AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANESTHESIA INDUCTION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); DRUG CONTAMINATION; DRUG MANUFACTURE; EDITORIAL; HUMAN; INTENSIVE CARE; LUNG ALVEOLUS CARBON DIOXIDE TENSION; LUNG ALVEOLUS OXYGEN TENSION; LUNG INJURY; OXYGENATION; PRIORITY JOURNAL; RISK FACTOR; NOTE;

ANESTHETICS, INHALATION; DRUG CONTAMINATION; HUMANS; NITRIC OXIDE; NITROUS OXIDE;

EID: 16544376252     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeh260     Document Type: Editorial

References (28)

1. Hess WC, Kannmacher J, Kruse MJ. Contamination of anaesthetic gases with nitric oxide and its influence on oxygenation: study in patients undergoing open heart surgery. Br J Anaesth 2003; 93 629-33
2. Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia. Br J Anaesth 1967; 39: 388-92
3. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′ -cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 1977; 74: 3203-7
4. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6
5. Ignarro LJ. Contributions to a quest. Nature 1987; 330: 526
6. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9
7. Rimar S, Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 1993; 88: 2884-7
8. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-47
9. Konstadt S. Nitric oxide: has it progressed from molecule of the year to wonder drug of the decade? J Cardiothorac Vasc Anesth 1995; 9: 625-6
10. Higenbottam T. Inhaled nitric oxide: a magic bullet? QJM 1993; 86: 555-8
11. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405
12. Payen DM. Is nitric oxide inhalation a 'cosmetic' therapy in acute respiratory distress syndrome? Am J Respir Crit Care Med 1998; 157: 1361-2
13. Tibby S, Shemie SD. Low-dose inhaled nitric oxide and oxygenation in pediatric hypoxic respiratory failure. Wrong bullet, wrong target. Crit Care Med 1999; 27: 871-2
14. Macrae DJ, Field D, Mercier JC, et al. Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Intensive Care Med 2004; 30: 372-80
15. Marczin N, Wright G, Yacoub M. Determinants of gas phase NO: influence of ventilation and pulmonary blood flow. In: Marczin N, Kharitonov S, Yacoub M. Barnes P, eds. Disease Markers in Exhaled Breath: Scientific Basis and Clinical Application. New York and Basel: Marcel Decker, 2002
16. Tan PS, Genc F, Delgado E, Kellum JA, Pinsky MR. Nitric oxide contamination of hospital compressed air improves gas exchange in patients with acute lung injury. Intensive Care Med 2002; 28: 1064-72
17. Marczin N, Riedel B, Gal J, Polak J, Yacoub M. Exhaled nitric oxide during lung transplantation. Lancet 1997; 350: 1681-2
18. (3244. Leo Szilard. Simpson's Contemporary Quotations. 1988)
19. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-5
20. Marczin N, Kovesi T, Royston D. Exhaled nitric oxide as a marker of lung injury in coronary artery bypass surgery. Br J Anaesth 2003; 90: 101-4
21. Gerlach H, Rossaint R, Pappert D, Knorr M, Falke KJ. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 1994; 343: 518-9
22. Lundberg JO, Settergren G, Gelinder S, Lundberg JM, Alving K, Weitzberg E. Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta Physiol Scand 1996; 158: 343-7
23. Settergren G, Angdin M, Astudillo R, et al. Decreased pulmonary vascular resistance during nasal breathing: modulation by endogenous nitric oxide from the paranasal sinuses. Acta Physiol Scand 1998; 163: 235-9
24. Adding LC, Bannenberg GL, Gustafsson LE. Gadolinium chloride inhibition of pulmonary nitric oxide production and effects on pulmonary circulation in the rabbit. Pharmacol Toxicol 1998; 83: 8-15
25. Adding LC, Agvald P, Persson MG, Gustafsson LE. Regulation of pulmonary nitric oxide by carbon dioxide is intrinsic to the lung. Acta Physiol Scand 1999; 167: 167-74
26. Stromberg S, Lonnqvist PA, Persson MG, Gustafsson LE. Lung distension and carbon dioxide affect pulmonary nitric oxide formation in the anaesthetized rabbit. Acta Physiol Scand 1997; 159: 59-67
27. Adding LC, Gustafsson LE. Determinants of gas phase NO: influence of ventilation and pulmonary blood flow. In: Marczin N, Kharitonov S, Yacoub M. Barnes P, eds. Disease Markers in Exhaled Breath: Scientific Basis and Clinical Application. New York and Basel: Marcel Decker, 2002
28. Marczin N. Exhaled nitric oxide and cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 2003; 126 1673-4